The role of metabotropic glutamate receptor (mGluR) ligands in parkinsonian muscle rigidity

Amino Acids

Volumn 19, Issue 1, 2000, Pages 95-101

  Wolfarth, S ^a   Konieczny, J ^a   Lorenc Koci, E ^a   Ossowska, K ^a   Pilc, A ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Amino acids; Ionotropic glutamate receptors; Metabotropic glutamate receptors; Parkinsonian like muscle rigidity; Striatum

Indexed keywords

1 AMINO 1,5 INDANDICARBOXYLIC ACID; 2 AMINOBICYCLO[3.1.0]HEXANE 2,6 DICARBOXYLIC ACID; 4 CARBOXY 3 HYDROXYPHENYLGLYCINE; GLUTAMATE RECEPTOR AGONIST; GLUTAMIC ACID ANTAGONIST; HALOPERIDOL; LIGAND; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; ELECTROMYOGRAPHY; MALE; MUSCLE RIGIDITY; MUSCLE TONE; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RAT; REFLEX;

ANIMAL; BICYCLO COMPOUNDS; ELECTROMYOGRAPHY; GLYCINE; LIGANDS; MALE; MUSCLE RIGIDITY; PARKINSON DISEASE; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; SUPPORT, NON-U.S. GOV'T;

ANIMALIA; PARKINSONIA;

EID: 0033796468     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007260070038     Document Type: Article

References (20)

1. Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: Functional implications for treatment of parkinsonian symptoms
2. Different mode of 3-amino-1-hydroxy-2-pyrrolidone (HA-966) and 7-chlorokynurenic acid in the modulation of NMDA-sensitive glutamate receptors
3. Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats? Case of amantafdine and memantine
4. Novel systemically active antagonists of the glycine site of NMDA receptor - Behavioural characterisation
5. NMDA antagonists potentiate antiparkinsonian actions of L-DOPA in monoamine-depleted rats
6. L-701,324, a selective antagonist at the glycine site of the NMDA receptor, counteracts haloperidol-induced muscle rigidity in rats
7. LY35440, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats
8. Behavioral and neurochemical actions of the strychnine-insensitive glycine receptor antagonist, 7-chlorokynurenate, in rats
9. Pathophysiology of rigidity and akinesia in Parkinson's disease
10. Contribution of the glycine site of the NMDA receptors in rostral and intermediate-caudal parts of the striatum to the regulation of muscle tone in rats
11. Involvement of the nucleus accumbens in the myorelaxant effects of baclofen in rats
12. Does reserpine induce parkinsonian rigidity?
13. Haloperidol-increased muscle tone in rats as a model of parkinsonian rigidity
14. Some central effects of kynurenic acid, 7-chlorokynurenic acid, glycine site antagonists
15. Metabotropic glutamate receptors: A new target for the therapy of neurodegenerative disorders
16. The role of excitatory amino acids in experimental models of Parkinson's disease
17. NMDA receptors in the rostral and intermediate-caudal striatum play an opposite role in regulation of the muscle tone in rats
18. Antiparkinsonian action of MK-801 on the reserpine-induced rigidity: A mechanomyographic analysis
19. The influence of dizocilpine (MK-801) on the reserpine-enhanced electromyographic stretch reflex in rats
20. Myorelaxant effect of baclofen injected to nucleus accumbens septi